Dysferlin mutations in LGMD2B, Miyoshi myopathy, and atypical dysferlinopathies

Archive ouverte

Nguyen, Karine | Bassez, Guillaume | Bernard, Rafaelle | Krahn, Martin | Labelle, Véronique | Figarella-Branger, Dominique | Pouget, Jean | Hammouda, El Hadi | Béroud, Christophe | Urtizberea, Andoni | Eymard, Bruno | Leturcq, France | Lévy, Nicolas

Edité par CCSD ; Wiley -

International audience. DYSF encoding dysferlin is mutated in Miyoshi myopathy and Limb-Girdle Muscular Dystrophy type 2B, the two main phenotypes recognized in dysferlinopathies. Dysferlin deficiency in muscle is the most relevant feature for the diagnosis of dysferlinopathy and prompts the search for mutations in DYSF. DYSF, located on chromosome 2p13, contains 55 coding exons and spans 150 kb of genomic DNA. We performed a genomic analysis of the DYSF coding sequence in 34 unrelated patients from various ethnic origins. All patients showed an absence or drastic decrease of dysferlin expression in muscle. A primary screening of DYSF using SSCP or dHPLC of PCR products of each of 55 exons of the gene was followed by sequencing whenever a sequence variation was detected. All together, 54 sequence variations were identified in DYSF, 50 of which predicting either a truncated protein or one amino-acid substitution and most of them (34 out of 54) being novel. In 23 patients, we identified two pathogenic mutations, while only one was identified in 11 patients. These mutations were widely spread in the coding sequence of the gene without any mutational "hotspot."

Suggestions

Du même auteur

Analysis of the DYSF mutational spectrum in a large cohort of patients

Archive ouverte | Krahn, Martin | CCSD

International audience. Dysferlinopathies belong to the heterogeneous group of autosomal recessive muscular dystrophies. Mutations in the gene encoding dysferlin (DYSF) lead to distinct phenotypes, mainly Limb Girdl...

Convergence of patient- and physician-reported outcomes in the French National Registry of Facioscapulohumeral Dystrophy

Archive ouverte | Sanson, Benoît | CCSD

International audience. Facioscapulohumeral muscular dystrophy (FSHD) is among the most prevalent muscular dystrophies and currently has no treatment. Clinical and genetic heterogeneity are the main challenges to a ...

Caractérisation phénotypique et génomique des patients Becker avec délétion des exons 45-55

Archive ouverte | Gargaun, Elena | CCSD

International audience. La dystrophie musculaire de Becker (BMD) est une pathologie liée à l’X qui se caractérise par une dégénérescence des muscles squelettiques et/ou associée à une cardiomyopathie. Les patients B...

Chargement des enrichissements...